- BusinessBusiness Insider•8 hours ago
The pharmaceutical company Mylan, which makes the EpiPen, is now saying it understated the profits it derives from the life-saving allergy drug by 60% in a congressional hearing last week, according to The Wall Street Journal. Mylan paid a 7.4% tax rate last year after moving its business to The Netherlands for tax purposes. The company's CEO, Heather Bresch, was called to the House of Representatives to answer for why her company had raised the EpiPen's price by 500% since it purchased the drug in 2007.
- LifestyleInvestopedia•2 hours ago
Baby boomers, born between 1946 and 1964, are heading into retirement in droves (about 10,000 a day, in fact). Along with the aging of this iconic cohort come lots of data about their poor preparation for their golden years. Insufficient preparedness
- financeEthan Wolff-Mann•5 hours ago
With more than 2 million accounts and credit cards opened without permission, Wells Fargo (WFC) has a lot of work to do to mend fences with the public. Are you a Wells Fargo customer who was impacted by the unauthorized accounts?